[{"text": "Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Dianthus Therapeutics, Inc. Wed, Jan 8, 2025, 3:00 PM 1 min read In This Article: DNTH -0.36% Dianthus Therapeutics, Inc. NEW YORK and WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced the company\u2019s participation at the 43 rd Annual J.P. Morgan Healthcare Conference. Marino Garcia, Chief Executive Officer, will present a corporate overview on Wednesday, January 15, 2025 at 9:00 a.m. PST / 12:00 p.m. EST in San Francisco. A live webcast of the Company\u2019s presentation may be accessed under \u201cNews and Events\u201d in the Investors section of the Dianthus Therapeutics website . About Dianthus Therapeutics Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases. To learn more, please visit www.dianthustx.com and follow us on LinkedIn . Contact Jennifer Davis Ruff Dianthus Therapeutics jdavisruff@dianthustx.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "DNTH", "date": "2025-01-08T12:00:00+00:00", "sentiment": {"score": 0.19309508427977562, "confidence": 0.20109540224075317, "probabilities": {"positive": 0.20109540224075317, "negative": 0.008000317960977554, "neutral": 0.7909042239189148}}, "embedding": [-0.09587225317955017, -0.1058739572763443, -0.030021077021956444, -0.11726051568984985, -0.03405380994081497, -0.02839864417910576, 0.021702324971556664, 0.16741114854812622, 0.07635677605867386, 0.02717377059161663, -0.20056812465190887, 0.04055069014430046, -0.025621341541409492, 0.06838611513376236, -0.030601786449551582, 0.08135724067687988, 0.10182541608810425, 0.03464120626449585, -0.012119379825890064, -0.03033304028213024, -0.03721800819039345, 0.07087969779968262, 0.042795468121767044, 0.02372010424733162, -0.09875482320785522, -0.006124452687799931, -0.03849175572395325, -0.02420015260577202, -0.10575336962938309, -0.1273401379585266, -0.12213905900716782, 0.018213964998722076, 0.010787318460643291, -0.020522477105259895, -0.0881311371922493, 0.040286652743816376, -0.08284885436296463, 0.08391628414392471, -0.08159767091274261, 0.010161361657083035, 0.04403654485940933, 0.022475913166999817, -0.045064959675073624, 0.017665015533566475, -0.0033879016991704702, -0.11597295850515366, -0.10823574662208557, 0.04962071031332016, 0.07512013614177704, 0.07666053622961044, -0.10113153606653214, -0.050220098346471786, 0.11105523258447647, 0.027033671736717224, -0.09763813018798828, -0.026778489351272583, -0.1567118763923645, -0.12345319241285324, -0.05198023468255997, 0.005734013393521309, 0.04370848461985588, 0.0438225083053112, 0.08616913855075836, -0.042508047074079514, 0.09009147435426712, -0.06741620600223541, -0.05564528703689575, 0.09987969696521759, 0.04991232603788376, -0.12809844315052032, -0.018680743873119354, -0.06696207821369171, -0.023774396628141403, 0.14963680505752563, -0.015556459315121174, 0.12054383754730225, 0.04380069673061371, 0.1262165606021881, 0.16737239062786102, -0.05590987578034401, 0.09039068967103958, 0.14241275191307068, 0.14589029550552368, 0.1588411182165146, -0.06544972956180573, 0.12893478572368622, -0.05543762817978859, 0.10983643680810928, -0.056187935173511505, -0.08579398691654205, 0.06517140567302704, -0.04490320757031441, -0.024093998596072197, 0.0675419345498085, -0.016323065385222435, -0.09999813884496689, 0.005134154111146927, -0.031553369015455246, 0.11387907713651657, 0.08016245812177658, -0.037996333092451096, 0.06478195637464523, -0.03642294183373451, -0.06268184632062912, -0.14198845624923706, -0.07349835336208344, -0.03878530487418175, 0.051422759890556335, 0.0721772238612175, -0.03387872129678726, -0.08559829741716385, 0.0738479495048523, 0.04004828259348869, -0.05524671822786331, -0.06295964866876602, 0.15701766312122345, -0.07713443785905838, -0.03321654722094536, 0.09761351346969604, -0.051256213337183, 0.03557821363210678, -0.005111441016197205, -0.02057846076786518, -0.018926991149783134, 0.06756062060594559, 0.13335423171520233, -0.10647723823785782, 8.943525424304718e-33, 0.06275365501642227, 0.07667596638202667, 0.16349276900291443, 0.08506841957569122, -0.08786514401435852, 0.001804382773116231, -0.07159009575843811, -0.009649381041526794, -0.09025972336530685, -0.04544217512011528, -0.11510647088289261, -0.07255949825048447, 0.04943307116627693, 0.11578232049942017, -0.16426993906497955, -0.026002958416938782, -0.012284819968044758, -0.018508370965719223, 0.01613607443869114, -0.06671171635389328, 0.016602687537670135, 0.12769505381584167, -0.09181351214647293, 0.09510158002376556, 0.05138580501079559, 0.026715096086263657, -0.018961187452077866, 0.11805529147386551, 0.07716087996959686, 0.032587211579084396, -0.1247025728225708, -0.013029398396611214, 0.06135902553796768, -0.05506539344787598, -0.10964163392782211, -0.09440866112709045, -0.11874278634786606, -0.14774036407470703, -0.011248868890106678, -0.022414175793528557, 0.0001724812900647521, 0.02003128081560135, -0.14837157726287842, -0.0371849499642849, 0.12542763352394104, -0.05842204764485359, -0.025540627539157867, 0.038552477955818176, -0.005340497940778732, -0.02406681329011917, 0.042534757405519485, 0.018779821693897247, 0.027675127610564232, -0.06261564791202545, -0.024566402658820152, 0.024121778085827827, -0.12128244340419769, -0.01799153722822666, 0.13335302472114563, 0.1512768268585205, 0.02879714034497738, 0.03150283172726631, -0.10138233751058578, -0.0017046959837898612, -0.10368286073207855, 0.03571830317378044, -0.04815030097961426, -0.0027556202840059996, -0.048479679971933365, 0.12181653082370758, 0.0010093094315379858, -0.06032309681177139, 0.07694275677204132, 0.025310633704066277, 0.06355812400579453, -0.11978165060281754, 0.093763567507267, 0.1183723658323288, -0.011964384466409683, 0.07233494520187378, 0.06407306343317032, 0.07221967726945877, -0.06790052354335785, 0.1938406378030777, 0.04484338313341141, -0.11566751450300217, -0.008841036818921566, -0.08880233764648438, -0.10316106677055359, 0.05322258174419403, 0.12612055242061615, 0.027363095432519913, -0.08337350934743881, 0.13444213569164276, 0.05789202079176903, -1.11102553864579e-32, 0.016902387142181396, -0.06163948401808739, -0.10027342289686203, -0.006975253112614155, 0.05369577929377556, -0.004172001965343952, 0.05271410197019577, 0.021796220913529396, 0.12910324335098267, -0.07051711529493332, 0.07923337817192078, 0.05092616006731987, -0.052430659532547, -0.06135638430714607, -0.15511050820350647, 0.018709484487771988, 0.006276867818087339, 0.08701909333467484, -0.1336289495229721, 0.10087660700082779, -0.014133994467556477, 0.20149853825569153, 0.019264528527855873, -0.1552969217300415, 0.14417079091072083, 0.009761638008058071, 0.02493131160736084, 0.1313711553812027, 0.007546212989836931, 0.003108009696006775, 0.03884395211935043, 0.06261800229549408, -0.23401746153831482, 0.01343690324574709, -0.013394294306635857, -0.04931539669632912, 0.04883456975221634, -0.09827270358800888, -0.011310896836221218, -0.12362562119960785, -0.05082685872912407, -0.04261386767029762, -0.09245450049638748, 0.025050658732652664, 0.12359805405139923, 0.10513755679130554, -0.007873966358602047, -0.006122614722698927, 0.09539815783500671, 0.03707383573055267, -0.07955615222454071, -0.03896355256438255, 0.0854855626821518, -0.025735579431056976, -0.02592978999018669, -0.021950984373688698, 0.03492298349738121, 0.04261261224746704, 0.030775578692555428, 0.116736501455307, -0.050989702343940735, -0.056848134845495224, 0.027981089428067207, 0.04735118895769119, -0.014377308078110218, 0.014350729063153267, 0.027392806485295296, 0.10438099503517151, 0.0865492895245552, -0.0723787471652031, -0.04863523691892624, 0.029418526217341423, 0.017453406006097794, 0.009476350620388985, 0.03036550059914589, 0.0697593167424202, -0.06895533949136734, -0.10950417816638947, -0.11770179122686386, 0.024961434304714203, -0.08987598121166229, -0.048349592834711075, -0.031927689909935, 0.06183762475848198, 0.05816938355565071, 0.1342470347881317, -0.013112002983689308, 0.0441628135740757, -0.10163892060518265, 0.06068956479430199, -0.019973905757069588, -0.16158869862556458, -0.13874676823616028, 0.04440633952617645, -0.03149830922484398, -1.0065319600016664e-07, 0.22038501501083374, -0.12466751784086227, -0.013485620729625225, -0.18928833305835724, -0.062100768089294434, 0.003196706296876073, -0.05116486921906471, 0.04589071869850159, -0.03806840628385544, 0.14597851037979126, 0.09046358615159988, 0.14636632800102234, -0.10525746643543243, -0.0026269566733390093, -0.03753066062927246, -0.02787158451974392, 0.024431949481368065, 0.060725897550582886, -0.09043750166893005, -0.07819642871618271, -0.03682074695825577, 0.0487811304628849, 0.029934680089354515, -0.012616132386028767, 0.06677567958831787, -0.15352673828601837, 0.021245598793029785, -0.012188296765089035, 0.030995415523648262, -0.06672737747430801, -0.0501338355243206, 0.04387299716472626, -0.01955331303179264, -0.02853490225970745, -0.010765221901237965, -0.07376408576965332, -0.048253413289785385, 0.049329496920108795, 0.07900283485651016, -0.07161567360162735, 0.021149329841136932, 0.0211995467543602, -0.026398709043860435, 0.018005376681685448, 0.027768615633249283, -0.04172388091683388, -0.0637299194931984, 0.04059503600001335, 0.0030001902487128973, -0.14515429735183716, -0.04533562436699867, -0.05848098173737526, 0.06067653372883797, -0.03381166234612465, -0.08307460695505142, 0.18416094779968262, -0.11110615730285645, -0.15034280717372894, 0.036432914435863495, -0.11177390813827515, -0.04723551496863365, -0.0571722537279129, 0.11328525096178055, 0.023012395948171616], "changes": {"1wk": -22.28303666903855}}, {"text": "PREMIUM TD Cowen Initiates Coverage on Dianthus Therapeutics With Buy Rating MT Newswires Fri, Dec 20, 2024, 3:30 PM Dianthus Therapeutics (DNTH) has an average rating of Buy and mean price target of $52.60, according PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "DNTH", "date": "2024-12-20T12:30:48+00:00", "sentiment": {"score": 0.03479021601378918, "confidence": 0.048679012805223465, "probabilities": {"positive": 0.048679012805223465, "negative": 0.013888796791434288, "neutral": 0.9374321699142456}}, "embedding": [-0.0910959243774414, -0.10471219569444656, -0.03301456198096275, -0.0631244033575058, 0.08397284150123596, -0.043416086584329605, 0.03749898448586464, 0.23127727210521698, 0.033402953296899796, 0.1325451284646988, -0.08966773748397827, 0.05065155029296875, 0.052558477967977524, -0.04798497259616852, -0.0023042578250169754, -0.03930000960826874, 0.18467988073825836, 0.006775483954697847, 0.06588570773601532, 0.017488891258835793, -0.18001773953437805, 0.122527115046978, 0.1391472965478897, -0.005684268660843372, 0.17827652394771576, -0.14482611417770386, -0.0063232737593352795, -0.02678772434592247, 0.04301096498966217, -0.05712772160768509, -0.047312356531620026, -0.030855199322104454, -0.07075250893831253, -0.04174087941646576, -0.08307990431785583, -0.151762455701828, -0.02078939974308014, 0.012403600849211216, -0.1759050190448761, 0.19259974360466003, 0.15254762768745422, -0.03923576697707176, -0.17047804594039917, 0.0166318342089653, -0.09941412508487701, -0.08382588624954224, -0.22326041758060455, 0.1938759833574295, 0.2094302773475647, 0.08943586051464081, 0.007624602410942316, 0.022528396919369698, 0.1936456561088562, -0.023068107664585114, -0.10808651894330978, -0.10965949296951294, -0.1426737904548645, 0.05080211162567139, 0.018754828721284866, -0.01027748640626669, 0.08083692938089371, 0.017954781651496887, -0.06317967176437378, -0.046823255717754364, 0.007103235460817814, -0.0003597714239731431, -0.21863201260566711, 0.06852909922599792, 0.07343428581953049, -0.18743887543678284, 0.004420670215040445, 0.06913494318723679, 0.07742344588041306, -0.05230676382780075, -0.02022329345345497, 0.17613519728183746, 0.10862302780151367, -0.054390933364629745, 0.17360976338386536, -0.048307936638593674, 0.008525967597961426, -0.03738580271601677, 0.14199846982955933, 0.045073818415403366, 0.10404748469591141, 0.02315044403076172, 0.1046447902917862, 0.0720290020108223, -0.002040462801232934, -0.20231997966766357, 0.2079477161169052, -0.07513438165187836, -0.23460109531879425, 0.015167822130024433, -0.25674059987068176, -0.028271635994315147, -0.06031092628836632, -0.08071211725473404, -0.05027421936392784, 0.10950013250112534, -0.013976878486573696, -0.0010033727157860994, -0.0792568176984787, -0.00877673551440239, -0.1966286301612854, -0.2264547049999237, -0.008638971485197544, 0.0863313376903534, 0.07510475069284439, 0.0465080551803112, -0.13100245594978333, 0.05612488090991974, 0.09785899519920349, 0.019640887156128883, -0.06338025629520416, 0.08229734003543854, -0.20039314031600952, -0.13439570367336273, 0.1398133933544159, -0.21580801904201508, 0.049191657453775406, 0.007625654339790344, -0.03594950586557388, 0.13035696744918823, -0.012561414390802383, -0.04011087119579315, 0.06588713079690933, 1.4778116613866097e-32, 0.09306610375642776, 0.11779356747865677, 0.03232719376683235, -0.24033819139003754, -0.10221296548843384, 0.04682616516947746, -0.03790226951241493, -0.03849228098988533, 0.02003488317131996, -0.023900525644421577, -0.23782044649124146, 0.0024289367720484734, -0.04024214297533035, 0.06153152883052826, -0.17812789976596832, -0.1373981386423111, -0.0547829307615757, 0.09846185147762299, 0.04968034848570824, 0.07725068181753159, -0.008528681471943855, 0.05330395698547363, -0.10308116674423218, 0.15409764647483826, -0.03348281979560852, -0.10115347802639008, 0.0877513438463211, 0.04196180775761604, 0.18423937261104584, 0.09478466957807541, -0.18562698364257812, -0.18517789244651794, 0.2175176739692688, -0.034204985946416855, -0.23700132966041565, 0.029051383957266808, -0.16071321070194244, -0.05610615387558937, -0.05723874643445015, -0.11388775706291199, -0.04272615909576416, 0.1396685242652893, -0.04192902520298958, 0.04619855061173439, -0.007095951586961746, 0.05687535181641579, 0.1515306830406189, 0.00967653188854456, -0.13672950863838196, -0.2245633751153946, -0.17887967824935913, 0.12446563690900803, -0.10127574950456619, 0.040917739272117615, -0.15094047784805298, -0.029186274856328964, -0.02292543835937977, -0.11159659922122955, 0.16324813663959503, 0.09664221107959747, 0.20620031654834747, 0.0032180582638829947, 0.03467963635921478, -0.11996642500162125, -0.12793093919754028, 0.09457051008939743, -0.1341734528541565, -0.1439090073108673, 0.011570180766284466, 0.12724153697490692, 0.1307736337184906, 0.09509360045194626, 0.15477627515792847, -0.17057764530181885, 0.09792163968086243, -0.025098595768213272, 0.04347372055053711, -0.01414494402706623, 0.12143976241350174, 0.03250642865896225, 0.05262133106589317, -0.10831955075263977, -0.10773707926273346, 0.14897720515727997, 0.14672628045082092, 0.06076502799987793, -0.16735298931598663, -0.0008340069325640798, -0.18621931970119476, 0.058641500771045685, 0.1650264412164688, 0.05475684627890587, -0.1662471890449524, -0.04715394601225853, 0.21066246926784515, -1.3705514752939223e-32, -0.15658937394618988, 0.15330779552459717, 0.05587632954120636, 0.09923979640007019, 0.11714058369398117, -0.03621375188231468, -0.16739816963672638, 0.1872725635766983, 0.2809830605983734, -0.01953434757888317, -0.03937250003218651, 0.051759012043476105, -0.15113022923469543, 0.07865980267524719, -0.008240102790296078, 0.07736067473888397, -0.017428604885935783, 0.05107817426323891, -0.015130029059946537, -0.052033718675374985, -0.05665289983153343, 0.2272714227437973, -0.03049745224416256, 0.11304116994142532, 0.15765434503555298, 0.0137876495718956, -0.0293499156832695, 0.15705108642578125, 0.10379738360643387, 0.013234506361186504, 0.008390727452933788, 0.03222671523690224, -0.20747750997543335, 0.14938300848007202, -0.09129390865564346, 0.03949740156531334, 0.17089660465717316, 0.09867240488529205, -0.11562406271696091, -0.02963484823703766, 0.10591892898082733, -0.14265525341033936, -0.0631692185997963, -0.050386182963848114, 0.18529139459133148, -0.10627807676792145, -0.015409012325108051, -0.040523260831832886, 0.20427168905735016, 0.06854397803544998, -0.09224338829517365, 0.05591864883899689, 0.19487136602401733, 0.057392749935388565, -0.2288522869348526, 0.01595538668334484, 0.024223115295171738, 0.18076956272125244, 0.01382631529122591, 0.1079556867480278, 0.1312333643436432, 0.1750170886516571, -0.1611655056476593, 0.04183962196111679, -0.07361491769552231, 0.05890374258160591, 0.08545628935098648, 0.09367440640926361, 0.06563668698072433, -0.036825988441705704, -0.1225874274969101, -0.022933216765522957, 0.16596175730228424, -0.11752910912036896, 0.012043018825352192, 0.09768077731132507, -0.005382940638810396, -0.040997061878442764, 0.004076305311173201, 0.08090056478977203, -0.1750098615884781, -0.06668782234191895, -0.014045815914869308, -0.07146421819925308, -0.021438924595713615, 0.059840038418769836, 0.05563931167125702, -0.017269885167479515, -0.30621325969696045, 0.18683022260665894, -0.1008002907037735, -0.16075986623764038, -0.13946250081062317, -0.06295280158519745, -7.372349500656128e-06, -1.0006620243530051e-07, 0.1639765501022339, -0.1381787806749344, 0.003860218683257699, -0.005649274215102196, 0.05126447230577469, -0.03216394782066345, -0.019363978877663612, 0.07397410273551941, -0.06344572454690933, 0.15110789239406586, 0.08382659405469894, 0.12426198273897171, -0.13059978187084198, -0.02446705847978592, -0.13602493703365326, -0.10053934156894684, 0.16714775562286377, 0.09207755327224731, -0.07510096579790115, -0.06665767729282379, 0.0010560281807556748, 0.08384761214256287, 0.06253945082426071, -0.11324873566627502, -0.05825500562787056, 0.10506685823202133, 0.038174357265233994, 0.03309761732816696, 0.12112274765968323, 0.018685445189476013, 0.018811628222465515, 0.12411949038505554, -0.08670111745595932, -0.07553791254758835, 0.09801679849624634, 0.004181772004812956, -0.25345996022224426, 0.255369633436203, 0.05929991975426674, 0.0013789385557174683, 0.004813733510673046, -0.13513639569282532, 0.023288175463676453, 0.07648581266403198, 0.014763166196644306, 0.047365952283144, -0.19719025492668152, -0.0746154934167862, 0.13069595396518707, -0.22441421449184418, 0.14363127946853638, -0.05574677884578705, 0.07527390122413635, -0.06624791771173477, -0.10010377317667007, 0.055172521620988846, -0.12715154886245728, -0.14189361035823822, -0.12169012427330017, -0.01693296618759632, -0.031302645802497864, -0.3043508529663086, 0.06410268694162369, 0.10093698650598526], "changes": {"1wk": -3.361341439939273, "1mo": -15.966383860816757}}, {"text": "Dianthus Therapeutics, Inc. (DNTH) Reports Q3 Loss, Tops Revenue Estimates Zacks Equity Research Fri, Nov 8, 2024, 1:35 AM 3 min read Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $3.78 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -25.42%. A quarter ago, it was expected that this company would post a loss of $0.50 per share when it actually produced a loss of $0.51, delivering a surprise of -2%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Dianthus Therapeutics, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $2.17 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 102.61%. This compares to year-ago revenues of $0.92 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Dianthus Therapeutics, Inc. Shares have added about 182.8% since the beginning of the year versus the S&P 500's gain of 24.3%. What's Next for Dianthus Therapeutics, Inc. While Dianthus Therapeutics, Inc. Has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Dianthus Therapeutics, Inc. Mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Story Continues It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.65 on $1.07 million in revenues for the coming quarter and -$2.28 on $4.16 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Cue Biopharma, Inc. (CUE), is yet to report results for the quarter ended September 2024. This company is expected to post quarterly loss of $0.20 per share in its upcoming report, which represents a year-over-year change of +16.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Cue Biopharma, Inc.'s revenues are expected to be $1.09 million, down 48% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dianthus Therapeutics, Inc. (DNTH) : Free Stock Analysis Report Cue Biopharma, Inc. (CUE) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "DNTH", "date": "2024-11-07T22:35:10+00:00", "sentiment": {"score": -0.04037918150424957, "confidence": 0.180484801530838, "probabilities": {"positive": 0.14010562002658844, "negative": 0.180484801530838, "neutral": 0.6794096231460571}}, "embedding": [-0.1325925588607788, 0.019169803708791733, -0.024018246680498123, -0.008054004982113838, -0.06914211809635162, -0.05787832289934158, -0.02153012901544571, 0.16497266292572021, 0.26205670833587646, 0.10019765794277191, -0.13432163000106812, 0.10927923023700714, 0.002423544880002737, -0.05414159595966339, -0.1588209867477417, -0.004267774522304535, 0.047146111726760864, 0.06227588653564453, -0.11486121267080307, 0.055032067000865936, -0.08232329785823822, 0.040768347680568695, 0.10650287568569183, 0.05049079656600952, 0.10383954644203186, 0.015928398817777634, -0.09981440007686615, 0.034624673426151276, -0.14169326424598694, -0.1563456952571869, -0.07113826274871826, 0.08024229854345322, 0.07996261119842529, -0.09903770685195923, -0.06226649507880211, -0.009795318357646465, -0.014353959821164608, 0.13754664361476898, 0.05679422616958618, 0.05596206337213516, 0.005263339728116989, 0.09063172340393066, -0.11473383009433746, 0.043464213609695435, -0.08419964462518692, -0.1810777485370636, -0.11288639903068542, 0.02691946178674698, 0.04790391027927399, 0.12240024656057358, -0.17562329769134521, -0.052694033831357956, 0.12289164960384369, 0.06979992985725403, -0.11936882883310318, -0.006926373578608036, -0.10809542238712311, -0.04525887593626976, -0.004584706388413906, 0.0697583258152008, 0.09657794237136841, 0.05866759642958641, 0.04143265634775162, -0.005594605579972267, 0.20669259130954742, -0.008466124534606934, -0.009113186039030552, 0.027069739997386932, -0.08214077353477478, -0.03246219828724861, 0.11613943427801132, -0.03699686378240585, -0.07007817924022675, 0.021179094910621643, -0.15366245806217194, 0.050073929131031036, 0.09442958235740662, 0.1759931445121765, 0.10216830670833588, -0.07955892384052277, 0.061293378472328186, 0.024214480072259903, -0.00880750548094511, -0.013048508204519749, -0.03479064255952835, 0.06017879396677017, 0.14308346807956696, 0.11453612148761749, 0.028218910098075867, -0.021679824218153954, -0.01541953906416893, -0.11204542219638824, -0.030582614243030548, -0.012829923070967197, -0.007628187537193298, 0.049776338040828705, -0.0801447182893753, -0.12222810089588165, 0.02510959655046463, 0.10926365852355957, 0.10673418641090393, 0.1331348419189453, -0.08527771383523941, -0.1736426204442978, -0.04481503739953041, -0.1770349144935608, 0.026933161541819572, 0.0015672650188207626, 0.05139964818954468, 0.07484479248523712, -0.080381840467453, 0.07476671785116196, -0.10630735754966736, 0.0413084402680397, -0.0362292155623436, 0.033100008964538574, -0.05084089934825897, 0.09906396269798279, 0.1338927447795868, 0.07259690761566162, 0.08975683152675629, 0.07895280420780182, 0.03065088763833046, 0.0024184705689549446, -0.013765247538685799, 0.03151876851916313, -0.15879371762275696, 7.619156183318727e-33, 0.0411946177482605, 0.08567410707473755, 0.04751421511173248, -0.03191199153661728, -0.09001876413822174, 0.0015655849128961563, -0.04392414912581444, -0.014534547924995422, -0.03763524442911148, -0.15973469614982605, -0.16152845323085785, 0.04156610742211342, 0.013662189245223999, -0.1264374852180481, -0.05953539162874222, -0.08278123289346695, -0.03462912142276764, 0.052312418818473816, 0.047126151621341705, -0.0824589729309082, 0.006437595002353191, 0.04533842206001282, -0.06757248193025589, 0.07527341693639755, 0.028280265629291534, -0.01332771871238947, -0.0674731433391571, 0.05976742133498192, -0.08010417968034744, 0.03109711967408657, 0.030613938346505165, -0.01821494847536087, 0.08228057622909546, -0.18199145793914795, -0.1234552413225174, -0.08652074635028839, -0.039780035614967346, -0.03324923664331436, 0.11801661550998688, 0.05635417252779007, -0.14958050847053528, 0.08371800184249878, -0.12396235764026642, -0.14039689302444458, -0.04633982852101326, 0.033918365836143494, 0.06540074944496155, 0.06376679241657257, -0.045413561165332794, -0.08637852966785431, -0.06741778552532196, 0.017448116093873978, 0.029357802122831345, -0.019607188180088997, -0.08845578134059906, 0.00941452942788601, -0.06506029516458511, -0.2095007747411728, 0.043934643268585205, 0.14740681648254395, 0.17441213130950928, 0.22390805184841156, 0.03408059477806091, -0.04716808721423149, -0.2680553197860718, 0.10678461939096451, -0.00176179688423872, 0.06981685757637024, -0.0643664002418518, 0.21671342849731445, -0.051304422318935394, -0.06003490090370178, 0.14150802791118622, -0.09118714928627014, 0.15631066262722015, -0.10281598567962646, -0.0010614488273859024, -0.033846255391836166, 0.0790698230266571, 0.07276266813278198, 0.07233881950378418, -0.03581652417778969, -0.044761065393686295, 0.04405030235648155, 0.06576132774353027, -0.015308540314435959, -0.0012357826344668865, 0.04461268335580826, -0.04697533696889877, 0.016578732058405876, 0.08375923335552216, -0.05461255460977554, -0.081200510263443, 0.09524320065975189, 0.10126575827598572, -7.972454683878211e-33, -0.10624950379133224, 0.05128266289830208, -3.131292760372162e-05, 0.00251047988422215, 0.027004269883036613, -0.07651776075363159, -0.0052901944145560265, 0.11273971199989319, 0.036568835377693176, -0.04579181596636772, -0.00623244047164917, 0.05303328111767769, -0.13959376513957977, 0.07949207723140717, -0.0645672157406807, 0.025049563497304916, 0.05776526778936386, -0.06254136562347412, 0.0016159368678927422, -0.07700799405574799, 0.019150253385305405, 0.25407591462135315, -0.08688846230506897, 0.03215192258358002, 0.09875058382749557, 0.08664781600236893, 0.024797122925519943, 0.18993130326271057, 0.04048136621713638, -0.044760845601558685, 0.03284144774079323, -0.012211162596940994, -0.22847487032413483, 0.08303610235452652, -0.003195654833689332, -0.032902736216783524, -0.05341538041830063, -0.15091466903686523, -0.06200612336397171, -0.10942263156175613, 0.1315498948097229, 0.02408081665635109, 0.02620895579457283, 0.026922916993498802, 0.12450453639030457, -0.04349035024642944, 0.035834912210702896, 0.03672153875231743, 0.25188860297203064, 0.12816211581230164, -0.040750887244939804, -0.015308558009564877, -0.05262000486254692, 0.16505569219589233, -0.1292528659105301, 0.04070195555686951, -0.08246579021215439, 0.0634908676147461, -0.15790393948554993, 0.07276107370853424, -0.02176458016037941, 0.10054022818803787, 0.013482410460710526, 0.11888640373945236, -0.03474241495132446, 0.01224211510270834, 0.01633545197546482, 0.055581871420145035, 0.02652594819664955, -0.07894740998744965, 0.0041195983067154884, -0.06884096562862396, 0.08963772654533386, -0.1374903917312622, -0.002574359066784382, 0.25672289729118347, -0.06110334396362305, -0.19599983096122742, -0.09076595306396484, 0.008204186335206032, -0.018427744507789612, 0.05198641121387482, 0.03116200864315033, 0.019160792231559753, -0.12447667866945267, 0.17481204867362976, 0.018053516745567322, -0.006392704788595438, -0.096287801861763, 0.02046794444322586, 0.010754933580756187, -0.21034491062164307, -0.1262257993221283, 0.011957187205553055, 0.030258595943450928, -1.0018290197422175e-07, 0.0783424824476242, -0.07838224619626999, 0.04102407395839691, -0.05849751457571983, 0.10141788423061371, -0.0919734388589859, 0.04298831522464752, 0.03684235364198685, 0.047754917293787, 0.14575299620628357, 0.08808013796806335, 0.0544542632997036, -0.2044363170862198, 0.043484654277563095, -0.11102351546287537, -0.003164423629641533, -0.0071806455962359905, 0.07717806100845337, -0.026411013677716255, -0.1623823195695877, -0.06414682418107986, 0.014279068447649479, 0.13448089361190796, -0.08785365521907806, -0.0038916640914976597, -0.05922924727201462, -0.029956551268696785, -0.03454715013504028, -0.031844668090343475, 0.016848664730787277, 0.12626898288726807, 0.007648494094610214, 0.05188937485218048, 0.030651992186903954, -0.03455743193626404, -0.10953371226787567, 0.016190888360142708, 0.1168653666973114, 0.03786947578191757, 0.020688597112894058, -0.024034906178712845, -0.05570051819086075, 0.03819854184985161, 0.05268951877951622, -0.03342754766345024, -0.09306485950946808, -0.08896172046661377, 0.013554392382502556, 0.01204149704426527, -0.2760181128978729, 0.14147013425827026, -0.08171087503433228, 0.06176834553480148, 0.028793226927518845, 0.0454939529299736, 0.10152406990528107, -0.19623687863349915, -0.047565191984176636, -0.21748146414756775, -0.036934979259967804, 0.07030801475048065, -0.24471907317638397, 0.13163305819034576, 0.08123694360256195], "changes": {"1wk": -14.749163557443822, "1mo": -18.42809464608508}}, {"text": "Dianthus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags editorial-team@simplywallst.com (Simply Wall St) Sun, Nov 10, 2024, 4:05 PM 1 min read In This Article: DNTH -0.36% Dianthus Therapeutics ( NASDAQ:DNTH ) Third Quarter 2024 Results Key Financial Results Net loss: US$25.2m (loss widened by 71% from 3Q 2023). US$0.73 loss per share. NasdaqCM:DNTH Earnings and Revenue Growth November 10th 2024 All figures shown in the chart above are for the trailing 12 month (TTM) period Dianthus Therapeutics Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates significantly. Earnings per share (EPS) missed analyst estimates by 23%. Looking ahead, revenue is forecast to grow 59% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are up 3.7% from a week ago. Risk Analysis Be aware that Dianthus Therapeutics is showing 3 warning signs in our investment analysis and 2 of those are potentially serious... Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "DNTH", "date": "2024-11-10T13:05:43+00:00", "sentiment": {"score": 0.09522978961467743, "confidence": 0.11971722543239594, "probabilities": {"positive": 0.11971722543239594, "negative": 0.024487435817718506, "neutral": 0.8557953834533691}}, "embedding": [0.009913983754813671, -0.012890699319541454, -0.10216401517391205, -0.014724602922797203, 0.015768593177199364, 0.0292842797935009, -0.08813323825597763, 0.1792422980070114, 0.06743816286325455, 0.06067923456430435, -0.1779278963804245, 0.09198297560214996, -0.002422305988147855, -0.03231718763709068, -0.1051875650882721, -0.014204341918230057, -0.047932107001543045, -0.015895649790763855, -0.06729104369878769, 0.06140223890542984, -0.05076198652386665, 0.03989025205373764, 0.015555199235677719, 0.014649941585958004, 0.044793590903282166, -0.0366334542632103, -0.04707133769989014, 0.018412267789244652, -0.12736058235168457, -0.14617715775966644, -0.0796537771821022, 0.07903772592544556, 0.11337152868509293, -0.09617090970277786, -0.039000339806079865, 0.09575778245925903, -0.05774529650807381, 0.09662041068077087, 0.06455951184034348, 0.03421903774142265, 0.09480243921279907, -0.018944747745990753, -0.08631724119186401, 0.04420359432697296, -0.001680196262896061, -0.15114499628543854, -0.10454942286014557, 0.031016720458865166, 0.0545135959982872, 0.05874161049723625, -0.19773370027542114, -0.04265158623456955, 0.0635051354765892, 0.02899947017431259, -0.02872820571064949, -0.05468587204813957, -0.10084886103868484, -0.08404307067394257, 0.007424248848110437, -0.11426591128110886, 0.11470186710357666, 0.05859409645199776, 0.014951923862099648, -0.029255324974656105, 0.1539461612701416, -0.08627060055732727, -0.046037063002586365, 0.13313232362270355, -0.03775999695062637, -0.017831960693001747, 0.05642330273985863, -0.08925358951091766, -0.13630057871341705, 0.08369870483875275, -0.11201772838830948, 0.15477722883224487, 0.1188853457570076, 0.18362094461917877, 0.1328907310962677, -0.09590926021337509, 0.07370343804359436, 0.06681055575609207, -0.021843381226062775, -0.007013776805251837, -0.10365255922079086, 0.05057186260819435, 0.07308460772037506, 0.0667445957660675, 0.012257947586476803, -0.02204216830432415, 0.17410795390605927, -0.08180403709411621, -0.023603780195116997, 0.04572701081633568, 0.04305781424045563, -0.03933926671743393, -0.12615109980106354, -0.13170181214809418, -0.00024889898486435413, 0.08656305819749832, 0.15408271551132202, 0.06284121423959732, -0.09344104677438736, -0.07400387525558472, -0.13344407081604004, -0.13354982435703278, -0.02514627017080784, 0.03547251224517822, 0.017195826396346092, 0.037886232137680054, -0.10551828145980835, 0.14037801325321198, -0.10348116606473923, -0.006395092234015465, 0.015457025729119778, 0.007037580478936434, -0.09668774157762527, -0.06505616754293442, 0.16825681924819946, 0.003171948017552495, 0.04790667071938515, 0.11073237657546997, 0.03057948499917984, 0.005439020227640867, 0.0004305455950088799, -0.05133095011115074, -0.12028095126152039, 1.3175056764083342e-32, -0.003937810193747282, 0.05039531737565994, 0.060643140226602554, -0.07807102799415588, -0.1101132184267044, 0.004607209470123053, -0.06690160930156708, -0.055214978754520416, -0.013407750986516476, -0.13825158774852753, -0.20342932641506195, 0.09265843033790588, 0.06295736134052277, -0.06598516553640366, -0.07407364249229431, -0.05008680745959282, 0.038970354944467545, 0.030631178990006447, 0.057025618851184845, -0.05568290874361992, 0.005375836975872517, 0.0261931661516428, -0.0736016258597374, 0.09498243778944016, 0.09362123161554337, -0.08868816494941711, -0.0044233715161681175, -0.03410928323864937, -0.04078672081232071, 0.057145703583955765, -0.04820060357451439, -0.00464982632547617, 0.010006831027567387, -0.11765336990356445, -0.08828803896903992, -0.05740257352590561, -0.1663406491279602, -0.061415355652570724, 0.04948103055357933, 0.030918674543499947, -0.12144210934638977, 0.06617516279220581, -0.04095546156167984, -0.030834952369332314, 0.04249347746372223, 0.08207695186138153, 0.04811996594071388, 0.03855117782950401, -0.009201325476169586, -0.08710107207298279, -0.10044055432081223, 0.027266379445791245, -0.04705487936735153, -0.07838431000709534, -0.08759023249149323, 0.05262930691242218, -0.009010682813823223, -0.1477627456188202, 0.038367319852113724, 0.0979224443435669, 0.052729614078998566, 0.1706220656633377, -0.007233875337988138, -0.05546407029032707, -0.2542598247528076, 0.061784837394952774, -0.07140292227268219, 0.11070457100868225, -0.020268317312002182, 0.09473207592964172, -0.0686461478471756, -0.06953667849302292, 0.1935865432024002, -0.052609916776418686, 0.07010221481323242, -0.06051059067249298, 0.005355441477149725, 0.03251681849360466, 0.029599962756037712, 0.07851456850767136, 0.028530588373541832, 0.033976536244153976, 0.004926435183733702, -0.019952833652496338, -0.037239689379930496, -0.008091511204838753, 0.09209540486335754, 0.029771490022540092, -0.04480333998799324, 0.131733238697052, -0.005925578530877829, 0.02140923961997032, -0.10499347746372223, 0.18991535902023315, 0.029744582250714302, -1.4229146058352704e-32, -0.0951424390077591, 0.014852714724838734, 0.02778378687798977, -0.027822507545351982, 0.03697674721479416, 0.012044895440340042, -0.012468297965824604, 0.1308135837316513, 0.038167696446180344, -0.09694380313158035, 0.024562980979681015, 0.07565539330244064, -0.053854990750551224, 0.03307686746120453, -0.04930873215198517, 0.009546407498419285, 0.04953751713037491, -0.03386276960372925, -0.07561282813549042, 0.00851831678301096, -0.04016256704926491, 0.19262760877609253, -0.1957910656929016, 0.06354215741157532, 0.020078983157873154, 0.11316270381212234, 0.09198454767465591, 0.11845109611749649, -0.006121406331658363, -0.011633481830358505, 0.008078433573246002, 0.060145869851112366, -0.2665287256240845, 0.14159327745437622, -0.04958168417215347, 0.016019225120544434, 0.12075505405664444, -0.17595884203910828, -0.054440710693597794, -0.08451355993747711, 0.17066609859466553, 0.12445146590471268, -0.004930509719997644, -0.029555629938840866, 0.0735379010438919, -0.04525649547576904, 0.10947224497795105, 0.030814701691269875, 0.12332505732774734, 0.13794448971748352, 0.047579698264598846, 0.03472280502319336, 0.049276553094387054, 0.05200503021478653, -0.1049753725528717, -0.037228062748909, 0.005959431175142527, 0.013820827938616276, -0.10132398456335068, 0.1109682098031044, -0.00563593627884984, 0.10411189496517181, -0.044176071882247925, -0.029147330671548843, 0.001971549354493618, -0.04462786391377449, 0.04438037425279617, 0.019837774336338043, 0.08500274270772934, -0.061082061380147934, 0.03888244926929474, -0.007143345195800066, 0.042444437742233276, -0.08886181563138962, 0.0015257811173796654, 0.2014310657978058, -0.05872191861271858, -0.15594130754470825, -0.12297537177801132, 0.08708162605762482, -0.030250059440732002, 0.05614298954606056, 0.05030904710292816, 0.02165669947862625, -0.026651224121451378, 0.11424094438552856, 0.007986390963196754, -0.02002733387053013, -0.09882728010416031, 0.012452816590666771, -0.09179315716028214, -0.2045329213142395, -0.15729470551013947, 0.026276621967554092, 0.016513880342245102, -1.0031441632918359e-07, 0.08819626271724701, -0.11650967597961426, 0.10699185729026794, -0.010060337372124195, 0.03139306977391243, -0.09998933225870132, 0.023111753165721893, -0.0006008903728798032, 0.04260203242301941, 0.16436749696731567, 0.08390489965677261, 0.04330703988671303, -0.2441679984331131, -0.01974363625049591, -0.08571399003267288, 0.02358786016702652, -0.05167599767446518, 0.0625220239162445, -0.06282266229391098, -0.14902374148368835, 0.04568585008382797, 0.06618332862854004, -0.00938710942864418, -0.0385281927883625, 0.12474093586206436, -0.09977128356695175, -0.0037775340024381876, 0.06179557740688324, -0.009911605156958103, 0.018115505576133728, 0.07098892331123352, -0.041161708533763885, 0.03940223902463913, -0.04265955463051796, -0.01062975823879242, -0.0878298357129097, 0.1473298817873001, 0.04850555956363678, 0.026845993474125862, 0.10373127460479736, -0.0018213106086477637, -0.03078947588801384, 0.05060437694191933, 0.023409709334373474, -0.06917835772037506, -0.08740481734275818, -0.09453186392784119, 0.034269850701093674, 0.0730818510055542, -0.20223990082740784, 0.10522351413965225, -0.10963969677686691, 0.0951593816280365, 0.06000067666172981, 0.0437261201441288, 0.08639440685510635, -0.14168007671833038, -0.0782652422785759, -0.10629923641681671, -0.04111676663160324, 0.03290152922272682, -0.25567394495010376, 0.07799705862998962, 0.10973593592643738], "changes": {"1wk": -15.819817620354728, "1mo": -12.576575751777167}}, {"text": "Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results Dianthus Therapeutics, Inc. Fri, Nov 8, 2024, 12:01 AM 11 min read In This Article: DNTH -0.36% Dianthus Therapeutics, Inc. Initiation of a single, two-part, pivotal Phase 3 trial of DNTH103 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) anticipated by YE\u201924 Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results anticipated in 2H\u201925 Phase 2 MoMeNtum trial of DNTH103 in Multifocal Motor Neuropathy (MMN) ongoing; top-line results anticipated in 2H\u201926 Approximately $343 million of cash provides runway into 2H\u201927 NEW YORK and WALTHAM, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today reported financial results for the third quarter ending September 30, 2024 and provided an update on recent business achievements. \u201cWe are excited to expand DNTH103 beyond gMG and MMN into CIDP before year end. Like gMG and MMN, CIDP has significant unmet needs where a best-in-class, potent classical pathway inhibitor can potentially make a meaningful difference in the lives of patients. We believe this single, two-part, pivotal Phase 3 trial will support BLA filing in adult patients with CIDP and we anticipate initiating the trial by year-end 2024,\u201d said\u00a0Marino Garcia, Chief Executive Officer of Dianthus Therapeutics. \u201cWe continue to be confident in the pipeline-in-a-product potential of DNTH103 across multiple autoimmune diseases, supported by our proof-of-concept in vitro data most recently presented at AANEM and ICNMD and competitor clinical data that further validate targeting the classical pathway and active C1s.\u201d DNTH103 Clinical Development DNTH103 is an investigational, clinical-stage, potent monoclonal antibody engineered to selectively target the classical pathway by inhibiting only the active form of the C1s protein, a clinically validated complement target. DNTH103 is enhanced with YTE half-life extension technology designed to enable a more convenient subcutaneous, self-administered injection dosed as infrequently as once every two weeks. DNTH103 has the potential to be a best-in-class pipeline-in-a-product across a range of autoimmune disorders with high unmet need. Generalized Myasthenia Gravis (gMG) Phase 2 MaGic gMG trial ongoing: The MaGic trial is a global, randomized, double-blind, placebo-controlled Phase 2 trial in patients with gMG who are acetylcholine receptor (AChR) antibody positive, and it remains on track to report top-line results in 2H\u201925. Poster presentations at AANEM and ICNMD: Encore poster presentations at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting in Savannah, Georgia and at the 18 th International Congress on Neuromuscular Diseases (ICNMD) in Perth, Australia highlighted preclinical and in vitro data describing the potentially differentiated profile of DNTH103 in a disease model of gMG. Story Continues Multifocal Motor Neuropathy (MMN) Phase 2 MoMeNtum MMN trial ongoing: The MoMeNtum trial is a global, randomized, double-blind, placebo-controlled Phase 2 trial designed to evaluate the safety, tolerability, and efficacy of DNTH103 in patients with MMN, and it remains on track to report top-line results in 2H\u201926. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Initiation of a Phase 3 trial in CIDP anticipated by YE\u201924: Dianthus plans to initiate a single, two-part, randomized withdrawal Phase 3 trial of DNTH103 in CIDP by YE\u201924. In the open label Part A of this trial, participants will be administered a loading dose followed by 300mg DNTH103 administered every 2 weeks (Q2W) via subcutaneous (S.C.) injection for up to 13 weeks. Part A includes an interim responder analysis of a pre-defined number of participants. Only participants who respond to DNTH103 in Part A will be randomized into Part B, a double-blind, placebo-controlled treatment period of up to 52 weeks, where they will be assessed for prevention of relapse, safety and tolerability, followed by an open-label extension period. The Company believes this single pivotal trial will support BLA filing in adult patients with CIDP. Additional details regarding Phase 3 trial design and timelines will be provided by YE\u201924. Poster presentations at AANEM and ICNMD: Encore poster presentations at the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting in Savannah, Georgia and at the 18 th International Congress on Neuromuscular Diseases (ICNMD) in Perth, Australia highlighted preclinical and in vitro data describing the potentially differentiated profile of DNTH103 in a disease model of CIDP, in addition to head-to-head affinity and pharmacodynamic (PD) potency data for DNTH103 compared to riliprubart. Corporate Updates Effective September 16, 2024, Steven Romano, M.D., was appointed to the Dianthus Therapeutics Board of Directors. Dr. Romano is a pharmaceutical executive with more than 28 years of experience in drug development across a wide range of therapeutic and disease areas. He currently serves as Executive Vice President, Chief Research and Development Officer at Silence Therapeutics. Third-Quarter 2024 Financial Results Cash Position - $342.6 million of cash, cash equivalents and investments as of September 30, 2024 is projected to provide runway into the second half of 2027. R&D Expenses - Research and development (R&D) expenses for the quarter ended September 30, 2024 were $25.5 million, inclusive of $1.7 million of stock-based compensation, compared to $8.0 million for the quarter ended September 30, 2023, which included $0.4 million of stock-based compensation. This increase in R&D expenses was primarily driven by higher clinical costs, chemistry, manufacturing and controls (CMC) costs and increased headcount to support DNTH103 Phase 2 and Phase 3 development. G&A Expenses - General and administrative (G&A) expenses for the quarter ended September 30, 2024 totaled $6.5 million, inclusive of stock-based compensation of $2.2 million, compared to $8.7 million for the quarter ended September 30, 2023, which included $0.8 million of stock-based compensation. This decrease in G&A expenses was primarily due to lower personnel costs. Net Loss - Net loss for the quarter ended September 30, 2024 was $25.2 million or $0.74 per share (basic and diluted) compared to $14.8 million or $3.78 per share (basic and diluted) for the quarter ended September 30, 2023. About DNTH103 DNTH103 is an investigational, clinical-stage, potent monoclonal antibody engineered to selectively target the classical pathway by inhibiting only the active form of the C1s protein, a clinically validated complement target. DNTH103 is enhanced with YTE half-life extension technology designed to enable a more convenient subcutaneous, self-administered injection dosed as infrequently as once every two weeks. Additionally, selective inhibition of the classical complement pathway may lower patient risk of infection from encapsulated bacteria by preserving immune activity of the lectin and alternative pathways. As the classical pathway plays a significant role in disease pathology, DNTH103 has the potential to be a best-in-class pipeline-in-a-product across a range of autoimmune disorders with high unmet need. Dianthus is building a neuromuscular franchise with DNTH103 following the initiation of the Phase 2 MaGic trial in generalized Myasthenia Gravis in 1Q\u201924 and the Phase 2 MoMeNtum trial in Multifocal Motor Neuropathy in 3Q\u201924, and initiation of a Phase 3 trial in Chronic Inflammatory Demyelinating Polyneuropathy anticipated by YE\u201924. DNTH103 is an investigational agent that is not approved as a therapy in any indication in any jurisdiction worldwide. About Dianthus Therapeutics Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases. To learn more, please visit www.dianthustx.com and follow us on LinkedIn . Cautionary Statement Regarding Forward-Looking Statements Certain statements in this press release, other than purely historical information, may constitute \u201cforward-looking statements\u201d within the meaning of the federal securities laws, including for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995, express or implied statements regarding future plans and prospects, including statements regarding the expectations or plans for discovery, preclinical studies, clinical trials and research and development programs, in particular with respect to DNTH103, and any developments or results in connection therewith, including the target product profile of DNTH103; the anticipated timing of the initiation and results from those studies and trials; expectations regarding the time period over which the Company\u2019s capital resources are expected to be sufficient to fund its anticipated operations; and expectations regarding the market and potential opportunities for complement therapies, in particular with respect to DNTH103. The words \u201copportunity,\u201d \u201cpotential,\u201d \u201cmilestones,\u201d \u201crunway,\u201d \u201cwill,\u201d \u201canticipate,\u201d \u201cachieve,\u201d \u201cnear-term,\u201d \u201ccatalysts,\u201d \u201cpursue,\u201d \u201cpipeline,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201c intend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpossible,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201cstrive,\u201d \u201cwould,\u201d \u201caim,\u201d \u201ctarget,\u201d \u201ccommit,\u201d and similar expressions (including the negatives of these terms or variations of them) generally identify forward-looking statements, but the absence of these words does not mean that statement is not forward looking. Actual results could differ materially from those included in the forward-looking statements due to various factors, risks and uncertainties, including, but not limited to, that preclinical testing of DNTH103 and data from clinical trials may not be predictive of the results or success of ongoing or later clinical trials, that the development of DNTH103 or the Company's other compounds may take longer and/or cost more than planned, that the Company may be unable to successfully complete the clinical development of the Company\u2019s compounds, that the Company may be delayed in initiating, enrolling or completing its planned clinical trials, and that the Company's compounds may not receive regulatory approval or become commercially successful products. These and other risks and uncertainties are identified under the heading \"Risk Factors\" included in the Company\u2019s Annual Report on Form 10-K for the period ended December 31, 2023, and other filings that the Company has made and may make with the SEC in the future. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. The forward-looking statements in this press release speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. Dianthus undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Contact Jennifer Davis Ruff Dianthus Therapeutics jdavisruff@dianthustx.com DIANTHUS THERAPEUTICS, INC. Condensed Consolidated Balance Sheets (in thousands, except share and per share data) (unaudited) September\u00a030, 2024 December\u00a031, 2023 Assets Current assets: Cash and cash equivalents $ 33,671 $ 132,325 Short-term investments 247,452 41,393 Receivable from related party 1,390 294 Unbilled receivable from related party 1,293 184 Prepaid expenses and other current assets 3,683 3,255 Total current assets 287,489 177,451 Long-term investments 61,482 \u2014 Property and equipment, net 189 185 Right-of-use operating lease assets 352 615 Other assets and restricted cash 4,736 1,154 Total assets $ 354,248 $ 179,405 Liabilities and Stockholders\u2019 Equity Current liabilities: Accounts payable $ 7,572 $ 2,610 Accrued expenses 7,727 6,504 Current portion of deferred revenue - related party 100 100 Current portion of operating lease liabilities 311 417 Total current liabilities 15,710 9,631 Deferred revenue - related party 640 736 Long-term operating lease liabilities \u2014 168 Total liabilities 16,350 10,535 Commitments and contingencies Stockholders\u2019 equity: Preferred stock \u2014 \u2014 Common stock 29 15 Additional paid-in capital 483,140 258,231 Accumulated deficit (145,952 ) (89,423 ) Accumulated other comprehensive income 681 47 Total stockholders\u2019 equity 337,898 168,870 Total liabilities and stockholders\u2019 equity $ 354,248 $ 179,405 DIANTHUS THERAPEUTICS, INC. Condensed Consolidated Statements of Operations and Comprehensive Loss (in thousands, except share and per share data) (unaudited) Three Months Ended September\u00a030, Nine Months Ended September\u00a030, 2024 2023 2024 2023 Revenues: License revenue - related party $ 2,172 $ 924 $ 4,909 $ 2,369 Operating expenses: Research and development 25,544 7,960 56,692 24,060 General and administrative 6,528 8,723 18,165 13,527 Total operating expenses 32,072 16,683 74,857 37,587 Loss from operations (29,900 ) (15,759 ) (69,948 ) (35,218 ) Other income/(expense): Interest income 4,445 1,027 13,375 2,320 Gain on investment in related party 307 \u2014 307 \u2014 Loss on currency exchange, net (48 ) (16 ) (91 ) (53 ) Other income/(expense) 22 (15 ) (172 ) (41 ) Total other income 4,726 996 13,419 2,226 Net loss $ (25,174 ) $ (14,763 ) $ (56,529 ) $ (32,992 ) Net loss per share attributable to common stockholders, basic and diluted $ (0.74 ) $ (3.78 ) $ (1.73 ) $ (17.40 ) Weighted-average number of shares of common stock outstanding including shares issuable under equity classified pre-funded warrants, used in computing net loss per share of common stock, basic and diluted 34,236,728 3,906,886 32,614,771 1,896,605 Comprehensive loss: Net loss $ (25,174 ) $ (14,763 ) $ (56,529 ) $ (32,992 ) Other comprehensive income: Change in unrealized gains related to available for-sale debt securities 718 15 634 157 Total other comprehensive income 718 15 634 157 Total comprehensive loss $ (24,456 ) $ (14,748 ) $ (55,895 ) $ (32,835 ) View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "DNTH", "date": "2024-11-07T21:01:00+00:00", "sentiment": {"score": 0.7632980328053236, "confidence": 0.7711292505264282, "probabilities": {"positive": 0.7711292505264282, "negative": 0.007831217721104622, "neutral": 0.22103948891162872}}, "embedding": [-0.165223628282547, -0.18033792078495026, 0.01638970710337162, -0.123123899102211, -0.05798899009823799, -0.06148751825094223, 0.003023439086973667, 0.15524640679359436, 0.08438774198293686, 0.06583187729120255, -0.10274562239646912, 0.05173126608133316, -0.03581508249044418, 0.09831389784812927, -0.021627899259328842, 0.09764419496059418, 0.04938361048698425, 0.08775288611650467, -0.07830755412578583, -0.008734317496418953, -0.01116391085088253, -0.002694179303944111, 0.09752564132213593, 0.010539930313825607, -0.038787275552749634, -0.05970346927642822, -0.02401045523583889, 0.01241665706038475, -0.0803014263510704, -0.10255086421966553, -0.041143402457237244, 0.1306910663843155, -0.08581527322530746, 0.04120035469532013, -0.0346255786716938, -0.025326024740934372, -0.19448544085025787, 0.05971863120794296, -0.1272488534450531, -0.06317403167486191, 0.0994495153427124, -0.010241314768791199, -0.045295801013708115, -0.038840632885694504, 0.05532917380332947, -0.09656259417533875, -0.1406920999288559, 0.12644806504249573, 0.07927758991718292, 0.12852469086647034, -0.08306017518043518, -0.04686505347490311, 0.1172424852848053, 0.11550427973270416, 0.0019608165603131056, -0.02738954871892929, -0.1412450224161148, 0.011602094396948814, -0.07647213339805603, 0.04971594363451004, 0.06448110938072205, 0.03779957443475723, -0.03946958854794502, -0.10785266757011414, 0.13162225484848022, -0.036257095634937286, -0.020545125007629395, -0.01963193342089653, -0.051767125725746155, -0.06069009751081467, -0.05009254813194275, -0.07624977082014084, -0.10410742461681366, 0.1432381421327591, -0.06577283143997192, 0.14359457790851593, 0.04035389795899391, 0.08295701444149017, 0.13586372137069702, -0.16914089024066925, 0.07184819132089615, 0.19135504961013794, 0.14686326682567596, 0.13364744186401367, 0.013907372020184994, 0.15360599756240845, -0.09727618098258972, 0.1487538069486618, -0.048719435930252075, -0.0030244579538702965, 0.07134571671485901, -0.11119304597377777, -0.08081941306591034, 0.05480184406042099, -0.014677714556455612, -0.009119116701185703, -8.619669824838638e-05, -0.10893663763999939, 0.08623592555522919, 0.06551681458950043, 0.02682182937860489, 0.06374554336071014, -0.055474378168582916, -0.11083418875932693, -0.07008560001850128, 0.004317769780755043, 0.046764448285102844, -0.042285576462745667, 0.03368786349892616, -0.025799058377742767, -0.023465927690267563, 0.05459126830101013, 0.015401825308799744, -0.067437082529068, -0.04800891876220703, 0.18623942136764526, -0.03603687509894371, 0.06352465599775314, 0.23352167010307312, -0.07497034966945648, 0.004026132635772228, -0.05666566267609596, 0.002074341056868434, -0.06924796104431152, 0.006288532633334398, 0.11069141328334808, -0.09865526109933853, 1.1663847104137963e-32, 0.0061567397788167, -0.0068618254736065865, 0.025223085656762123, 0.02370288595557213, -0.0750727728009224, -0.09793773293495178, -0.010098879225552082, 0.13278327882289886, -0.10370979458093643, -0.04904765263199806, -0.11190624535083771, -0.11181085556745529, 0.06577634811401367, 0.1072492003440857, -0.10958406329154968, -0.0662313848733902, -0.01573507860302925, -0.015348842367529869, -0.0012503273319453, -0.08191923797130585, 0.10433859378099442, 0.024133363738656044, -0.016008544713258743, -7.277820259332657e-06, 0.01834246702492237, 0.02643352560698986, 0.018378188833594322, 0.15691980719566345, 0.15069374442100525, 0.0007609790191054344, -0.11368732154369354, 0.008338820189237595, 0.05961902439594269, -0.03287450224161148, -0.15945538878440857, -0.047004975378513336, -0.06509336084127426, -0.20181508362293243, 0.03803694248199463, 0.037862345576286316, 0.02297702059149742, 0.022926639765501022, -0.07271712273359299, -0.18050044775009155, 0.09018562734127045, -0.08952772617340088, -0.00854059774428606, -0.087959423661232, -0.04694899916648865, -0.013528268784284592, 0.10114060342311859, 0.04144570603966713, 0.10162413865327835, -0.09557490050792694, -0.11220768094062805, -0.013093791902065277, -0.15838801860809326, -0.02620432898402214, 0.1036398857831955, 0.09824493527412415, -0.00459199957549572, -0.08892621099948883, -0.11638210713863373, 0.02443815767765045, -0.08328478038311005, 0.14558833837509155, -0.03996045142412186, -0.022570576518774033, -0.12029892206192017, 0.066557876765728, 0.01396927796304226, -0.1356983184814453, 0.1333959996700287, 0.03685000538825989, 0.1629694700241089, -0.06663484126329422, 0.11169838160276413, 0.09441514313220978, 0.021694980561733246, -0.0002212671097368002, -0.046250130981206894, 0.12418577075004578, -0.07141140103340149, 0.27373766899108887, 0.09786331653594971, -0.0896502435207367, 0.04567091539502144, -0.12177978456020355, -0.1360059380531311, -0.03868009150028229, 0.14187097549438477, 0.032754603773355484, -0.043090175837278366, 0.17723560333251953, 0.02297789603471756, -1.3001500900656185e-32, -0.06407567858695984, 0.033421266824007034, -0.12064202129840851, -0.0673370510339737, -0.0012327025178819895, 0.06100059300661087, 0.09492506086826324, -0.07219338417053223, 0.15494287014007568, -0.19495528936386108, 0.09662781655788422, 0.0405769906938076, -0.062180906534194946, -0.05964696779847145, -0.09075118601322174, -0.053448691964149475, -0.13011617958545685, 0.048227421939373016, -0.11059346795082092, 0.18964380025863647, 0.11121539771556854, 0.25639283657073975, 0.02607233077287674, -0.04711563512682915, 0.08994089812040329, -0.031959183514118195, 0.10724544525146484, 0.17383384704589844, -0.04954420030117035, 0.08783076703548431, 0.03156374767422676, 0.012634718790650368, -0.2445775270462036, -0.044588956981897354, -0.007932158187031746, -0.02624654956161976, 0.04899853095412254, -0.12242032587528229, -0.17579326033592224, -0.04193539917469025, 0.013505024835467339, 0.028985215350985527, -0.01238362118601799, 0.013337071985006332, 0.14404058456420898, 0.10934783518314362, 0.022184299305081367, -0.011667367070913315, 0.1058233380317688, 0.04202551022171974, -0.010492403991520405, 0.011038203723728657, 0.07327084243297577, 0.03800320625305176, -0.00852420087903738, -0.006517864763736725, 0.14850187301635742, 0.007241074927151203, -0.07901190221309662, 0.08396244049072266, -0.2124265432357788, 0.047846317291259766, 0.10532520711421967, -0.013346130959689617, 0.08505116403102875, 0.1196499615907669, 0.029827846214175224, 0.028706831857562065, 0.08254443854093552, -0.08996064215898514, -0.14498282968997955, 0.04567128047347069, -0.011025821790099144, -0.003852419788017869, -0.031957101076841354, 0.08989522606134415, -0.007395845837891102, -0.09294494986534119, -0.03721173107624054, -0.05439362674951553, -0.018624598160386086, -0.03139539435505867, -0.12721334397792816, 0.06303749233484268, 0.014907043427228928, 0.07008302956819534, -0.023081880062818527, 0.0729307234287262, -0.039715155959129333, 0.09137029945850372, 0.034912776201963425, -0.0808178186416626, -0.09267497062683105, 0.06787429749965668, -0.10348604619503021, -1.0060890076601936e-07, 0.2366730123758316, 0.008434640243649483, 0.047777384519577026, -0.1948361098766327, -0.0025671403855085373, -0.024077173322439194, -0.0598086342215538, 0.05164893716573715, -0.05950794368982315, 0.12528620660305023, 0.13584521412849426, 0.14428141713142395, -0.044843338429927826, -0.010554061271250248, -0.060507990419864655, -0.05667496472597122, 0.07086609303951263, 0.040827833116054535, -0.11137942969799042, -0.08928664773702621, -0.07687144726514816, 0.06615009158849716, -0.012475291267037392, -0.06674513965845108, 0.17458420991897583, -0.14665859937667847, 0.01987074688076973, 0.04712584242224693, 0.02272897958755493, -0.10936971753835678, 0.0025472964625805616, 0.049711424857378006, 0.01824083738029003, 0.009527194313704967, -0.005933821201324463, -0.00886678695678711, 0.0036389436572790146, 0.09893861413002014, 0.05504611134529114, -0.024988288059830666, 0.0621163509786129, -0.01023550983518362, -0.01226729340851307, -0.009648032486438751, 0.031593065708875656, -0.0662805587053299, -0.13806287944316864, -0.055099159479141235, 0.02237454429268837, -0.12720517814159393, -0.029500650241971016, -0.019927890971302986, 0.03986555337905884, -0.07261621206998825, -0.05915530025959015, 0.042099833488464355, -0.1981976479291916, -0.08739921450614929, -0.0140378437936306, -0.12819714844226837, 0.045014042407274246, -0.07255756109952927, 0.011427560821175575, -0.024199265986680984], "changes": {"1wk": -14.749163557443822, "1mo": -18.42809464608508}}, {"text": "Gilead Sciences (GILD) Q3 Earnings and Revenues Surpass Estimates Zacks Equity Research Thu, Nov 7, 2024, 1:15 AM 3 min read In This Article: GILD +1.21% Gilead Sciences (GILD) came out with quarterly earnings of $2.02 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 27.85%. A quarter ago, it was expected that this HIV and hepatitis C drugmaker would post earnings of $1.61 per share when it actually produced earnings of $2.01, delivering a surprise of 24.84%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Gilead , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $7.55 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 7.94%. This compares to year-ago revenues of $7.05 billion. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Gilead shares have added about 11.4% since the beginning of the year versus the S&P 500's gain of 21.2%. What's Next for Gilead? While Gilead has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Gilead: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.56 on $7.06 billion in revenues for the coming quarter and $3.75 on $27.67 billion in revenues for the current fiscal year. Story Continues Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Dianthus Therapeutics, Inc. (DNTH), is yet to report results for the quarter ended September 2024. This company is expected to post quarterly loss of $0.59 per share in its upcoming report, which represents a year-over-year change of +84.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Dianthus Therapeutics, Inc.'s revenues are expected to be $1.07 million, up 16.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report Dianthus Therapeutics, Inc. (DNTH) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "DNTH", "date": "2024-11-06T22:15:14+00:00", "sentiment": {"score": 0.14598608016967773, "confidence": 0.1785680204629898, "probabilities": {"positive": 0.1785680204629898, "negative": 0.03258194029331207, "neutral": 0.7888500690460205}}, "embedding": [-0.10931237041950226, -0.06273356825113297, 0.011944043450057507, 0.04283478483557701, -0.02375021204352379, -0.029685497283935547, -0.06591320782899857, 0.14515624940395355, 0.19210125505924225, 0.11123006045818329, -0.08305428177118301, 0.1205158680677414, -0.02794983610510826, -0.08742344379425049, -0.17430518567562103, -0.06644676625728607, 0.13339275121688843, 0.004455413669347763, -0.08218159526586533, 0.12097431719303131, -0.02056673914194107, -0.09232015907764435, 0.1385613977909088, -0.04109177738428116, 0.11538682878017426, 0.06477567553520203, -0.07661885023117065, 0.020261380821466446, -0.16846147179603577, -0.0662292018532753, 0.018678639084100723, 0.0711178109049797, 0.15262937545776367, -0.08616483211517334, -0.20583218336105347, -0.07446275651454926, 0.029792513698339462, 0.13704223930835724, 0.1282445639371872, -0.0060464972630143166, 0.055133819580078125, -0.0005742553621530533, -0.09952254593372345, -0.07556318491697311, -0.041385214775800705, -0.17024357616901398, 0.03022991120815277, 0.006823915988206863, -0.01646849699318409, 0.05705302953720093, -0.16637268662452698, -0.140473872423172, 0.046982359141111374, -0.013076252304017544, -0.033827923238277435, 0.04185211658477783, -0.0699043720960617, -0.19866561889648438, 0.09316438436508179, 0.05049314349889755, -0.03113122284412384, 0.022134575992822647, 0.024314559996128082, 0.07157659530639648, 0.14435115456581116, -0.057826146483421326, 0.1156432181596756, 0.12141327559947968, -0.10943955183029175, -0.059364400804042816, 0.09723552316427231, 0.11551402509212494, -0.14633944630622864, -0.039529792964458466, -0.046864163130521774, 0.1365143358707428, 0.08495122939348221, 0.08266384154558182, 0.19038143754005432, -0.16607558727264404, 0.0778396725654602, -0.042586736381053925, 0.013795236125588417, -0.04429062083363533, 0.13784757256507874, 0.005448642186820507, 0.18968158960342407, 0.1536247432231903, -0.02790939249098301, -0.07851998507976532, 0.06713950634002686, -0.02474340796470642, -0.06693816930055618, -0.005459500476717949, -0.02750565856695175, 0.013089333660900593, -0.06730998307466507, -0.11714575439691544, -0.048970069736242294, 0.02943674847483635, 0.06955800205469131, 0.14175420999526978, 0.046054355800151825, -0.16009697318077087, -0.014933162368834019, -0.14914856851100922, 0.04602556675672531, 0.03646779805421829, 0.023731566965579987, 0.007656424306333065, -0.00939325150102377, 0.06290504336357117, -0.16872116923332214, -0.04088146984577179, -0.032353390008211136, 0.0855160802602768, -0.0027528321370482445, 0.11796779185533524, 0.02526090107858181, 0.10785432159900665, 0.04676669463515282, 0.08484433591365814, 0.017584722489118576, 0.006267995107918978, -0.04627098888158798, 0.048849012702703476, -0.11043240875005722, 8.789091915229563e-33, 0.0950002521276474, 0.008926784619688988, -0.07219350337982178, -0.046692028641700745, 0.048885226249694824, 0.06718312203884125, 0.01961817778646946, -0.05457429587841034, 0.044840581715106964, -0.18189525604248047, -0.09520353376865387, 0.047011833637952805, 0.007806381210684776, -0.035172175616025925, -0.049811094999313354, -0.10292141884565353, -0.023943407461047173, 0.010426421649754047, 0.012584930285811424, -0.09196216613054276, -0.016698375344276428, -0.06510985642671585, 0.018271993845701218, 0.021024663001298904, 0.04326669126749039, -0.019298890605568886, -0.08859343826770782, 0.024843543767929077, -0.08230649679899216, 0.060046400874853134, -0.012736276723444462, 0.023824958130717278, 0.08299992978572845, -0.20191900432109833, -0.09631669521331787, -0.05298729985952377, -0.06125221401453018, -0.07967410981655121, 0.19297799468040466, 0.07232671976089478, -0.07378648221492767, 0.05901859700679779, -0.03080998733639717, -0.14410188794136047, -0.04877934604883194, 0.07838204503059387, -0.12148264050483704, 0.09532471001148224, -0.07908624410629272, 0.08648288249969482, -0.022394701838493347, 0.031022142618894577, 0.020139707252383232, -0.043033167719841, -0.07241630554199219, 0.016901735216379166, -0.13467855751514435, -0.2051561176776886, -0.019337905570864677, 0.14916037023067474, 0.17554306983947754, 0.31082290410995483, 0.008313124068081379, 0.010817470028996468, -0.2628205418586731, 0.23812028765678406, -0.015433534979820251, 0.054185859858989716, -0.05316668748855591, 0.32382577657699585, -0.015694264322519302, -0.04272039234638214, 0.09309609979391098, -0.018777862191200256, 0.1407547891139984, -0.051014527678489685, -0.030680136755108833, -0.049130216240882874, 0.12184122949838638, 0.019090751186013222, 0.05568169057369232, 0.034260738641023636, 0.029604850336909294, 0.024996109306812286, 0.012375619262456894, 0.042278893291950226, 0.036120496690273285, 0.047859422862529755, -0.06780427694320679, -0.0633268877863884, 0.11141485720872879, 0.002411704510450363, -0.049630358815193176, 0.09090808033943176, -0.00616714172065258, -7.999350729308995e-33, -0.019579429179430008, 0.10370683670043945, -0.006660003215074539, -0.014963898807764053, -0.06860590726137161, 0.00850969273597002, 0.15306350588798523, 0.027238763868808746, 0.02198292687535286, -0.10461530089378357, 0.06519946455955505, -0.048722043633461, -0.13105323910713196, 0.06581888347864151, 0.02494022622704506, 0.05638791248202324, 0.03055126778781414, -0.15565967559814453, 0.043082378804683685, -0.014045868068933487, -0.0011744056828320026, 0.12339644134044647, -0.07156233489513397, 0.134516179561615, 0.08500535786151886, -0.004520265851169825, -0.01571045257151127, 0.13320323824882507, 0.01930154487490654, -0.07794936001300812, 0.004443500190973282, -0.046773530542850494, -0.17032894492149353, -0.016754349693655968, -0.08831827342510223, -0.009088768623769283, 0.04201609641313553, -0.17155450582504272, 0.016841553151607513, -0.014641494490206242, 0.18810251355171204, -0.0392972007393837, 0.006043080240488052, 0.05606040731072426, 0.043631844222545624, 0.08712223172187805, 0.046688515692949295, 0.06271086633205414, 0.16324135661125183, 0.034641604870557785, -0.01974903792142868, 0.015286511741578579, -0.029302271082997322, 0.19878292083740234, -0.16029003262519836, -0.007400361821055412, -0.04059259220957756, 0.05504915863275528, -0.2306637316942215, -0.004027476534247398, -0.15435177087783813, 0.18559685349464417, 0.05293381214141846, 0.03704024851322174, 0.00803283229470253, 0.032365258783102036, 0.07159291207790375, -0.029947321861982346, -0.02498140186071396, -0.19534555077552795, 0.03147383779287338, -0.12963707745075226, 0.08157636225223541, -0.17346149682998657, 0.003895792178809643, 0.30895930528640747, -0.06348568201065063, -0.17177529633045197, -0.11572539806365967, 0.022608701139688492, 0.09401583671569824, 0.04101244732737541, 0.07621193677186966, -0.028000468388199806, -0.19531092047691345, 0.09551848471164703, 0.05237778648734093, -0.07348275929689407, -0.05086101219058037, -0.022563617676496506, -0.11414936184883118, -0.20621754229068756, -0.12683594226837158, -0.010018838569521904, 0.1347077488899231, -9.987090976437685e-08, 0.07693886756896973, -0.04804085195064545, 0.04023284465074539, -0.08959989249706268, 0.13546954095363617, 0.03409092500805855, -0.031024370342493057, -0.031572163105010986, 0.1091175377368927, 0.11984110623598099, 0.11761519312858582, 0.07656668871641159, -0.20222428441047668, 0.0326102152466774, -0.16258880496025085, 0.1533968150615692, -0.09851560741662979, 0.009599080309271812, -0.021651314571499825, -0.18162819743156433, -0.1477348953485489, 0.08465447276830673, 0.12106174230575562, -0.12427223473787308, 0.05605514347553253, -0.10013493150472641, -0.1451018899679184, -0.10741133987903595, -0.03977704048156738, -0.0029788389801979065, 0.13834504783153534, -0.09441497921943665, 0.11292332410812378, 0.06537462770938873, 0.020764166489243507, -0.06479974836111069, 0.04679146781563759, 0.0701608955860138, 0.10515043139457703, 0.102516308426857, 0.052577175199985504, 0.006289339624345303, 0.0019758986309170723, 0.02082742191851139, -0.012097889557480812, -0.142446368932724, -0.12407274544239044, 0.022777337580919266, 0.008144848048686981, -0.16358670592308044, 0.12470103800296783, -0.005602370947599411, 0.10405631363391876, -0.019444303587079048, 0.04421418160200119, 0.02910328283905983, -0.24745264649391174, -0.07129271328449249, -0.18016374111175537, 0.006901059299707413, 0.15221847593784332, -0.30255064368247986, 0.10132797062397003, 0.15572760999202728], "changes": {"1wk": -10.404622515534093, "1mo": -17.06902578649758}}]